Prixa, a leading health-tech company, recently raised additional US$3 million funding, led by MDI and TPTF with participation from existing investors including Siloam Hospitals Group.
Aptar Pharma is expanding its digital healthsolutions driven by the impact of COVID-19 pandemic on patients and their ability to visit their physician or hospital.